Home Cart Sign in  
Chemical Structure| 1848959-10-3 Chemical Structure| 1848959-10-3

Structure of TAS4464
CAS No.: 1848959-10-3

Chemical Structure| 1848959-10-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TAS4464 selectively inhibits NAE relative to the other E1s UAE and SAE.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TAS4464

CAS No. :1848959-10-3
Formula : C21H23FN6O6S
M.W : 506.51
SMILES Code : O[C@@H]1[C@H](O)[C@@H](CNS(=O)(N)=O)O[C@]1(N2C=C(C#CC3=C(OCC)C=CC=C3F)C4=C(N)N=CN=C24)[H]
MDL No. :MFCD32067967
InChI Key :TZTRUHFXPVXWRD-QTQZEZTPSA-N
Pubchem ID :124121703

Safety of TAS4464

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02978235 Multiple Myeloma|NonHodgkin Ly... More >>mphoma Less << PHASE1 TERMINATED 2018-02-01 Center for Cancer and Blood Di... More >>sorders, Bethesda, Maryland, 20817, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, 48334, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, New Jersey, 07601, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Gabrail Cancer Center, Canton, Ohio, 44718, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.97mL

0.39mL

0.20mL

9.87mL

1.97mL

0.99mL

19.74mL

3.95mL

1.97mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories